Rhythm

AliveCor Now Detects Six Times as Many Cardiac Conditions as Any Other Personal ECG

Launch of expanded range of determinations cements AliveCor as the most comprehensive AI-enabled solution in personal ECG MOUNTAIN VIEW, Calif., Feb. 1, 2021 /PRNewswire/ — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today launched an expanded range of ECG determinations on its KardiaMobile devices. These new determinations are cleared by […]

CardioFocus Announces Expanded Partnership With Japan Lifeline

HeartLight® X3 Japan Launch Anticipated in Mid-2021 MARLBOROUGH, Mass., Feb. 2, 2021 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced today that it has expanded its existing partnership agreement with Japan Lifeline Co., Ltd. (JLL). The agreement extends the timeframe of the existing distribution […]

Medtronic Receives FDA Approval of DiamondTemp Ablation System for the Treatment of Patients with Atrial Fibrillation

Clinical Trial Demonstrates Procedural Efficiencies, Safety, Effectiveness and Non-Inferiority of DiamondTemp System DUBLIN, Jan. 29, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of the DiamondTemp™ Ablation (DTA) system which treats patients with recurrent, symptomatic paroxysmal atrial […]

CathVision clinical results to be presented at the AF Symposium

COPENHAGEN, Denmark, Jan. 29, 2021 /PRNewswire/ — CathVision ApS, a medical device company developing a novel cardiac electrophysiology system and artificial intelligence platform to guide ablation therapy for heart rhythm disorders, is featured at the 26th annual international AF Symposium, held online January 29-31st. On January 30th, Professor Josef Kautzner, Institute of Cardiology and Experimental Medicine […]

FARAPULSE Receives European Approval To Commercialize Its Leading Pulsed Field Ablation System To Treat Paroxysmal Atrial Fibrillation

– FARAPULSE becomes first company in the world to commercialize a cardiac PFA system – MENLO PARK, Calif., Jan. 29, 2021 /PRNewswire/ – FARAPULSE Inc. (“FARAPULSE” or “the Company”) today announced that it has received the Conformité Européene (CE) Mark for its FARAPULSE Pulsed Field Ablation (PFA) system for the treatment of […]

iRhythm Technologies Provides Statement on Medicare Administrative Contractor (MAC) Novitas Recent Rate Publication

SAN FRANCISCO, Jan. 29, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, commented on the recent publication by Novitas Solutions (“Novitas”) of rates applicable to the Current Procedural Terminology (CPT) codes 93241, 93243, 93245 and […]

VivaQuant Introduces Smallest One-Piece Mobile Cardiac Telemetry Device

The Rhythm Express RX-1 mini sets a new standard for patient comfort and simplicity ST. PAUL, Minn.–(BUSINESS WIRE)–VivaQuant, a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, is proud to announce launch of the RX-1 mini. The mini is the smallest one-piece mobile cardiac telemetry device on the […]

MedLumics Proprietary Technology to be presented at 26th Annual International AF Symposium

– MedLumics is developing a unique real-time, optically-guided ablation catheter to improve treatment of Atrial Fibrillation by RadioFrequency Ablation and Pulsed Field Ablation – Presentation on Direct Lesion Assessment using Photonics during AF Ablation MADRID, Jan. 28, 2021 /PRNewswire/ — MedLumics, a privately held medical technology company developing AblaView®, an optically-guided RadioFrequency […]

United Therapeutics Announces BREEZE Study of Investigational Tyvaso DPI™ Meets Primary Objective

Study demonstrated safety and tolerability of Tyvaso DPI™ in patients with PAH transitioning from Tyvaso® Inhalation Solution A separate study in healthy volunteers demonstrated comparable treprostinil exposure between Tyvaso DPI and Tyvaso Inhalation Solution Tyvaso DPI NDA filing anticipated in April 2021 with priority review SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, […]

Acutus Medical Suite of EP Products To Be Featured During Recorded Cases at AF Symposium 2021

Innovative Technologies Improve the Treatment of Persistent AF Patients CARLSBAD, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB) today announced the presentation of two mapping and ablation procedures during the 26th Annual International AF Symposium demonstrating the beneficial capabilities of guided ablation therapy utilizing the company’s entire diagnostic […]